Pathogenesis of type 1 diabetes: A viewpoint

Advances in Experimental Medicine and Biology

Volumn 552, Issue , 2004, Pages 317-321

  Von Herrath, Matthias G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CYCLOSPORIN A; GLUTAMATE DECARBOXYLASE; INSULIN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MATERNAL ANTIBODY; PANCREAS ISLET CELL ANTIBODY; TETRAMER;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; DIABETOGENESIS; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSPOT ASSAY; GENETIC PREDISPOSITION; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC INFILTRATION; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; PROGENY; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; T-LYMPHOCYTES;

EID: 12144259046     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (43)

1. Pietropaolo M, Eisenbarth GS. Autoantibodies in human diabetes. Curr Dir Autoimmun 2001; 4:252-282.
2. Naserke HE, Bonifacio E, Ziegler AG. Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes. J Clin Endocrinol Metab 2001; 86:4826-4833.
3. Bach J-F. Predictive medicine in autoimmune diseases: From the identification of genetic predisposition and environmental influence to precocious immunotherapy. Clin Immunol Immunopath 1994; 72:156-161.
4. Wrede G, Kiesel U, Freytag G et al. Chronic insulitis after partial islet damage by passive insulin antibody transfer. Horm Metab Res 1984; 16(1):97-101.
5. Seidel DK, Geiss HC, Donner MG et al. Course of islet autoantibody titers during Ig-immunoadsorption in a patient with newly diagnosed type 1 diabetes. J Autoimmun 1998; 11:273-277.
6. Greeley SAW, Katsumata M, Yu L et al. Elimination of maternally- transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 2002; In press.
7. Warram JH, Krolewski AS, Gottlieb MS et al. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 1984; 311:149-152.
8. Rulli M, Simell O. Avidity of islet cell autoantibodies in non-diabetic children and children with insulin-dependent diabetes. Autoimmunity 1999; 31:187-193.
9. Bendelac A, Boitard C, Bedossa P et al. Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. J Immunol 1988; 141:2625-2628.
10. Jansen A, Homo-Delarche F, Hooijkaas H et al. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 1994; 43:667-675.
11. Haskins K, McDuffie M. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 1990; 249:1433-1436.
12. Bach J-F. Insulin dependent diabetes mellitus as an autoimmune disease. Endocrine Reviews 1994; 15:516-542.
13. Conrad B, Weidmann E, Trucco G et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994; 371:351-355.
14. Kaufmann SH, von Herrath MG et al. 2nd IDS NOD T-cell Workshop. Diabetes 2001; In press.
15. Homann D, Holz A, Bot A et al. Autoreactive CD4+ lymphocytes protect from autoimmune diabetes via bystander suppression using the IL-4/STAT6 pathway. Immunity 1999; 11:463-472.
16. Reijonen H, Daniels TL, Lernmark A et al. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes 2000; 49:1621-1626.
17. Anthony DD, Lehmann PV. T-cell epitope mapping using the ELISPOT approach. Methods 2003; 260-269.
18. Charlton B, Lafferty KJ. The Thl/Th2 balance in autoimmunity. Curr Opin Immunol 1995; 7:793-798.
19. Ludewig B, Odermatt B, Landmann S et al. Dendritic cells induce autoimmune diabetes and maintain disease via De Novo formation of local lymphoid tissue. J Exp Med 1998; 188:1493-1501.
20. Jansen A, van Hagen M, Drexhage HA. Defective maturation and function of antigen-presenting cells in type 1 diabetes. Lancet 1995; 345:491-492.
21. Lenschow DJ, Ho SC, Sattar H et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995; 181:1145-1155.
22. de Seze J, Dubucquoi S, Leftanc D et al. IgG reactivity against citrullinated myelin basic protein in multiple sclerosis. J Neuroimmunol 2001; 117:149-155.
23. Todd JA, Wicker LS. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 2001; 15:387-395.
24. Merriman TR, Todd JA. Genetics of autoimmune disease. Curr Opin Immunol 1995; 7:786-792.
25. Todd JA, Aitman TJ, Cornall RJ et al. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 1991; 351:542-547.
26. Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995; 13:179-200.
27. McDevitt H, Singer S, Tisch R. The role of MHC class II genes in susceptibility and resistance to type I diabetes mellitus in the NOD mouse. Horm Metab Res 1996; 28:287-288.
28. Sonderstrup G, McDevitt HO. DR, DQ, and you: MHC alleles and autoimmunity. J Clin Invest 2001; 107:795-796.
29. Redondo MJ, Rewers M, Yu L et al. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ 1999; 318:698-702.
30. Serreze DV, Ottendorfer EW, Ellis TM et al. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000; 49:708-711.
31. Schwimmbeck PL, Dyrberg T, Oldstone MBA. Abrogation of diabetes in BB rats by acute virus infection. Association of viral-lymphocyte interactions. J Immunol 1988; 140:3394-3400.
32. Honeyman MC, Coulson BS, Stone NL et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at-risk for type 1 diabetes. Diabetes 2000; 49:1319-1324.
33. Kukreja A, Cost G, Marker J et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002; 109:131-140.
34. Sharif S, Arreaza GA, Zucker P et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001; 7:1057-1062.
35. von Herrath MG, Dockter J, Oldstone MBA. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1994; 1:231-242.
36. Pugliese A, Brown D, Garza D et al. Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest 2001; 107:555-564.
37. von Herrath MG, Coon B, Lewicki H et al. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. J Immunol 1998; 161:5087-5096.
38. Chatenoud L, Thervet E, Primo J et al. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 1994; 91:123-127.
39. Adorini L. 1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation. Curr Opin Invest Drugs 2002; 3:1458-1463.
40. Coon B, An L-L, Whitton JL et al. DNA immunization to prevent autoimmune diabetes. J Clin Invest 1999; 104:189-194.
41. Thomas HE, Parker JL, Schreiber RD et al. IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J Clin Invest 1998; 102:1249-1257.
42. Seewaldt S, Thomas HE, Ejrnaes M et al. Virus-induced autoimmune diabetes: Most beta-cells die through inflammatory cytokines and not perform from autoreactive (anti-viral) CTL. Diabetes 2000; 49:1801-1809.
43. Tisch R, Wang B, Serreze DV. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitipe dependent. J Immunol 1999; 163:1178-1187.